Victor Urrea

Barcelona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: May 21, 2026

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Journal: JCI insight
Published: October 09, 2025

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Journal: Open forum infectious diseases
Published: July 03, 2025

Tracking the soluble biomarkers of MIS-C and their association with clinical parameters and severity.

Tracking the soluble biomarkers of MIS-C and their association with clinical parameters and severity.

Journal: Pediatric research
Published: June 18, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Journal: mBio
Published: April 24, 2025

A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.

A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.

Journal: European urology
Published: March 12, 2025

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Journal: Journal of translational medicine
Published: March 07, 2025

Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.

Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.

Journal: PLoS pathogens
Published: March 03, 2025

Correction for Morón-López et al., "Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA".

Correction for Morón-López et al., "Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA".

Journal: Microbiology spectrum
Published: October 30, 2024

Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population.

Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population.

Journal: International journal of molecular sciences
Published: August 30, 2024

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Journal: The Journal of clinical investigation
Published: June 20, 2024
Showing 1-12 of 63

Last Updated: 09/26/2026